Effects of leukotrienes C4 and D4 on human isolated saphenous veins.

1. Vascular injury during the intra-operative procedures of bypass surgery may be the initiating event in the gradual deterioration in the patency of the graft. Adhesion of leukocytes to the vascular endothelium frequently accompanies preparation and insertion of the graft. However, little is known about the effects of vasoactive substances released from leukocytes on vein graft performance. 2. To determine whether leukotrienes are capable of affecting the tone of blood vessels used as coronary artery bypass grafts we studied the human saphenous vein as intact rings using an isolated organ bath technique. 3. LTC4 and LTD4 caused weak endothelium-dependent relaxations at lower concentrations (1 pM to 1 nM) and powerful endothelium-independent contractions at higher concentrations (3 nM to 0.1 microM). The maximum responses to LTC4 and LTD4 for relaxations were 21.1 +/- 4.8% and 28.6 +/- 3.4% (% of noradrenaline induced tone) respectively and 64.6 +/- 9.9% and 59.1 +/- 7.9% (% response to KCl) respectively for contractions. 4. The inhibitor of nitric oxide formation, L-NG-monomethyl L-arginine, prevented the relaxations to LTD4, but not LTC4 and unmasked endothelium-dependent contractions to LTD4 (32.9 +/- 11.3%). NG-monomethyl L-arginine had no effect on the contractions produced by LTC4 or LTD4. 5. Indomethacin augmented relaxations and contractions of saphenous vein to LTC4 from 22.5 +/- 5.6 to 40.02 +/- 8.7 (P < 0.05) and 48.8 +/- 5.5% to 74.7 +/- 7.6% (P < 0.01) respectively. LTD4 responses were not affected by indomethacin treatment. 6. In conclusion, leukotrienes mediate biphasic responses in the human saphenous vein.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  A. Ford-hutchinson,et al.  Increased Urinary Leukotriene Excretion in Patients With Cardiac Ischemia: In Vivo Evidence for 5‐Lipoxygenase Activation , 1992, Circulation.

[2]  L. V. von Segesser,et al.  Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. , 1991, Circulation research.

[3]  M. Yacoub,et al.  Characterization of 5-HT receptors in the human saphenous vein, implications for patency of bypass grafts , 1990 .

[4]  C. Dollery,et al.  Leukotriene C4 elimination and metabolism in man. , 1990, The Journal of allergy and clinical immunology.

[5]  E. Ohlstein,et al.  Rabbit Polymorphonuclear Neutrophils Elicit Endothelium-Dependent Contraction in Vascular Smooth Muscle , 1989, Circulation research.

[6]  L. Fleisher,et al.  Indomethacin and LY171883 modify porcine cardiopulmonary responses to leukotrienes. , 1989, Prostaglandins, leukotrienes, and essential fatty acids.

[7]  C. Nathan.  Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. , 1989, Blood.

[8]  J. Mehta,et al.  Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. , 1988, The American journal of physiology.

[9]  P. Sever,et al.  Action of Dopamine on Isolated Human Saphenous Veins , 1988, Journal of cardiovascular pharmacology.

[10]  J. Mehta,et al.  Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet aggregation. , 1986, Thrombosis research.

[11]  V. Fuster,et al.  Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. , 1986, Circulation.

[12]  F. A. Wali.  Effects of local anaesthetics on responses of human saphenous vein and bovine coronary artery to neurotransmitters, acetylcholine, noradrenaline and 5-hydroxytryptamine. , 1986, General pharmacology.

[13]  T. Ahmed,et al.  Direct and indirect effects of leukotriene D4 on the pulmonary and systemic circulations. , 1985, The American review of respiratory disease.

[14]  Robert A. Lewis,et al.  Distinct Sulfidopeptide Leukotriene Receptors , 1985 .

[15]  P. Piper.  Formation and actions of leukotrienes. , 1984, Physiological reviews.

[16]  J. Gleason,et al.  Effects of the leukotrienes on the vasculature and blood pressure of different species. , 1984, The Journal of pharmacology and experimental therapeutics.

[17]  Z. Werb,et al.  Secretory products of macrophages and their physiological functions. , 1984, The American journal of physiology.

[18]  J. Angus,et al.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin , 1983, Nature.

[19]  A. M. Lefer,et al.  Studies on the mechanism of leukotriene induced coronary artery constriction. , 1983, Prostaglandins.

[20]  N. Pawlowski,et al.  Leukotriene C promotes prostacyclin synthesis by human endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Harken,et al.  Platelet-mediated cardiac ischemia. , 1982, The Journal of surgical research.

[22]  W. Zapol,et al.  Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. , 1982, Science.

[23]  L. Letts,et al.  THE ACTIONS OF LEUKOTRIENES C4 AND D4 ON GUINEA‐PIG ISOLATED HEARTS , 1982, British journal of pharmacology.

[24]  S. Dahlén,et al.  Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey , 1982, Nature.

[25]  S. Ohkawa,et al.  Coronary vasoconstriction and PGI2 release by leukotrienes in isolated guinea pig hearts , 1981 .

[26]  F. Spencer,et al.  Vein Contraction and Smooth Muscle Cell Extensions as Causes of Endothelial Damage during Graft Preparation , 1981, Annals of surgery.

[27]  L. Hillis,et al.  Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. , 1981, The New England journal of medicine.

[28]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[29]  E. Corey,et al.  Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Bonchek.  Prevention of endothelial damage during preparation of saphenous veins for bypass grafting. , 1980, The Journal of thoracic and cardiovascular surgery.

[31]  H. Baumgartner,et al.  Platelet Adhesion, Release and Aggregation in Flowing Blood: Effects of Surface Properties and Platelet Function. , 1976, Thrombosis and Haemostasis.

[32]  J. Zahavi,et al.  Adenosine diphosphate induced platelet aggregation in myocardial infarction and ischemic heart disease. , 1973, Atherosclerosis.